text:
Fruit Biscotti
|Golden raisins
|1⁄3 Cup (5.33 tbs)
|Dry marsala
|2 Tablespoon
|All purpose flour
|2 3⁄4 Cup (44 tbs)
|1 Cup (16 tbs)
|Toasted sliced almonds
|1⁄3 Cup (5.33 tbs)
|Chopped crystallized ginger
|2 Tablespoon
|Baking powder
|1 Teaspoon
|Baking soda
|1⁄2 Teaspoon
|Ground cinnamon
|1⁄2 Teaspoon
|1⁄4 Teaspoon
|Egg white
|1 Teaspoon
|1 , rind grated
|1 , rind grated
|Frozen orange juice concentrate
|1 Tablespoon, thawed
Preheat the oven to 325°F.
Coat a baking sheet with no-stick spray.
Place the raisins and Marsala or apple juice in a small bowl.
Let soak for 10 minutes, or until the raisins are softened.
In a large bowl, combine the flour, sugar, almonds, ginger, baking powder, baking soda, cinnamon, and salt.
Mix well.
In a medium bowl, combine the eggs, egg white, vanilla, orange rind, lemon rind, and orange juice concentrate; mix well.
Stir in the raisins and their soaking liquid.
Pour into the flour mixture and mix well.
Divide the dough in half.
Shape each half into a 13"-long log; flatten to a 1 "thickness.
Transfer the logs to the prepared baking sheet and space them 2" apart.
Bake for 25 minutes, or until firm to the touch.
Remove the logs from the baking sheet and let cool on a wire rack for 10 minutes.
Reduce the oven temperature to 300°F.
Gut each roll diagonally into eighteen 1/2" slices.
Place the slices, cut side down, on the baking sheet.
Bake for 20 minutes.
Transfer to a wire rack and cool completely.
Recipe Summary
Rate It
Nutrition Rank
Nutrition Facts
Serving size: Complete recipe
Calories 2843 Calories from Fat 312
% Daily Value*
Total Fat 34 g52.5%
Saturated Fat 5.1 g25.6%
Trans Fat 0 g
Cholesterol 423 mg141%
Sodium 1990.1 mg82.9%
Total Carbohydrates 581 g193.6%
Dietary Fiber 23.4 g93.4%
Sugars 283.8 g
Protein 63 g126.6%
Vitamin A 17.4% Vitamin C 218.8%
Calcium 78.6% Iron 153.6%
*Based on a 2000 Calorie diet

subset: commoncrawl


text:
Sorry! The position you're looking for is no longer available. Check out other Accounting internships in Massachusetts below.
Results 1 — 10
Sort By:
Corporate Tax – Learn and Earn Internship – Fall 2016
Liberty Mutual Insurance — Boston, MA
July 30 2016
Description: GENERIC INTERN TEMPLATE W/O Job description GENERIC INTERN TEMPLATE W/O Job description Job: Primary Location: United States- Massachusetts-Boston Schedule: Part-time Salary: $16-$20 Edu…
Application Deadline: Available Year-round
Yardi Systems — North Waltham, MA
July 29 2016
As an Intern for the Resident Screening team, you will be responsible for gathering client data and validating for accuracy. You will also assist the existing Account Management team with research an…
Application Deadline: Available Year-round
Boston Public Market Fall Internship
Boston — Boston, MA
July 27 2016
Duration: September 2016 December 2016 Hours per week: Minimum 12 hours per week. Organization Overview: The Boston Public Market is a year-round, indoor market featuring fresh, locally sourced food b…
Application Deadline: 8/10/2016
Bruker Corporation — Billerica, MA
July 20 2016
HR Intern/HR Assistant All times are in Eastern Daylight Time. Req. # 2016-4017 # of Openings 1 Job Locations US-MA-Billerica Position Type Temporary Full-Time Posted Date 7/7/2016 More information ab…
Application Deadline: Available Year-round
Talent Intern Sourcer
KNF&T — Boston, MA
July 20 2016
KNF&T Staffing Resources is looking for a talent sourcer to join our team as an intern, starting this September. As the Talent Intern Sourcer at KNF&T, you will: - Partner with recruiters and hiring m…
Application Deadline: 8/31/2016
Events Intern
Nxtevent — Boston, MA
July 19 2016
Any world class destination deserves a world class team. NXTevent is the choice of the meetings, convention and incentive industry. As Boston's finest full service Event and Destination Management Com…
Application Deadline: Available Year-round
Assistant Actuary\Actuary���� Reserving���� International Consumer Markets
Liberty Mutual Insurance — Boston, MA
July 18 2016
Description: Advance your actuarial career at Liberty Mutual Insurance - A Fortune 100 Company! Job Summary: International Consumer Markets (ICM) Actuarial is seeking a highly motivated individual to…
Application Deadline: Available Year-round
Accounting Intern
Penrose Realty — Boston, MA
June 28 2016
Penrose Group consists of our Real Estate, Property Management and Construction companies. We have experienced tremendous growth in the past few years and are looking to expand even more. We currently…
Application Deadline: 8/31/2016
Accounting Internship - Part Time
Benchmark Senior Living — Waltham, MA
June 27 2016
COMPANY OVERVIEW: Benchmark, as the name implies, is committed to setting the standard of excellence in Senior Housing. Benchmark Senior Living, based centrally out of Waltham, Massachusetts, is the l…
Application Deadline: Available Year-round
Marketing and Human Resources Intern
Boston Newborn Care — Foxborough, MA
June 21 2016
I own a training and HR placement and referral company in Foxborough ma. I train nannies to care for newborns for families in the New England Area.Then I place the nannies in short term positions with…
Application Deadline: 8/31/2016


text:
Happy New Year! I seriously have to give myself an intervention to stop saying that every January. Is there an official cut-off?
I thought I'd post some photos of my Christmas and New Year's. We had a lovely trip down to Costa Rica (with some time in Nicaragua) over the holidays. I highly recommend the lush Guanacaste landscape for your next escape. The beaches are so VAST.
Another horrible beach (Costa Rica)
Masaya Volcano (Nicaragua)
M & G at VanDusen Lights
Shamelss selfie
New Year's Eve at the Hotel Vancouver
My handsome little man, Rhett. Aren't his chubs adorable?
This year will be a busy one for us! My days are starting to fill up with plans for the BIG MOVE. I always considered myself a minimalist, but I seem to have 3 carrier bags filled with clothes ready to be donated. Speaking of carrier bags....my addiction is a bit out of control. They are just so re-usable!


text:
The Week in Geek
Photo 1 of 9
ADVERTISEMENT ( more slides)
The Week in Geek
June busted onto the scene, and even though we haven't hit the official first day of Summer yet, it's feeling like it to me. The weather's not the only thing heating up: so is my workout, wedding stuff, celebrity tech, and video game releases! Check out my slideshow for anything you may have missed this week!


text:
Cheryl Ann Follansbee Barnett, 66, a longtime resident of Manhattan, died Friday, June 1, 2012, at her home in Manhattan, surrounded by her family.
This page and other exclusive local content require a subscription.
Terms of Service | Privacy Policy | The Manhattan Mercury, 318 North 5th Street, Manhattan, Kansas, 66502 | Copyright 2012
Reproduction of any kind is prohibited without written consent.


text:
Children's Riding Sport™ Pull-On Breeches keep kids comfortable and looking good in soft fabric with excellent shape retention and stretch. Available in great colors that kids will love!
The TuffRider® Children's Marathon Tight is perfect for everyday fun at the barn! Stretchy, durable and stylish, it's constructed in panels of smooth dynamic stretch material with a breathable strip of printed fabric down the outside of each leg. Modern silicone print knee patches and stretchy cuff hems.
Kerrits® Klassic Tights in four-way stretch fabric keep the young rider comfortable in the saddle. These riding tights have no-chafe seams for comfort against the skin. EcoSuede™ knee patches provide grip.
The Kerrits Kids' Performance Tight is made of four-way stretch, sueded fabric and with no-chafe seams. Your little rider will enjoy complete freedom of movement. EcoSuede™ knee patches help provide grip, while gripper elastic ankles keep pant legs in place.
The Devon-Aire® Versailles Jod is ideal year round. Four-way stretch fabric helps keep young athletes moving freely. Low-rise styling sits these jodphurs right above the hip. Features Clarino™ knee patches, cuffed hems, plush, an elastic waistband and more. Every purchase helps support the United State Pony Club.
Devon-Aire® Children's Versailles Breeches offer a silky feel and 4-ay stretch for comfort. This children's knee-patch breech is perfectly suited for showing and schooling and for wearing all year. A portion of the proceeds goes directly to support the USPC.
Children's riding tights by Devon-Aire in a whole wardrobe of colors. Durable 90% cotton/ 10% Lycra with flat seams for comfort and a drawstring waist so kids have room to grow. These are durable schooling tights at a great value.


text:
Many intro R books and guides start off with the practice of attaching a
data.frame so that you can call the variables by name. I have always found it favorable to call variables with
$ notation or square bracket slicing
[,2]. That way I can use multiple
data.frames without confusing them and/or use iteration to successively call columns of interest. I noticed Google recently posted coding guidelines for R which included the line
1) attach: avoid using it
How do people feel about this practice?


text:
Album Summary
- Shenyang (Bass Baritone)
- Tuomas Katajala (Tenor)
- Mari Palo (Soprano)
Notes & Reviews:
Ondine presents a couple of dramatic works by Dmitri Shostakovich: The Execution of Stepan Razin and the Zoya Suite. Winner of the 2007 BBC Cardiff Singer of the World competition, Shenyang embodies a 21st century bridge between the cultures of East and West. Recent highlights include a return to the New York Metropolitan, and debuts at the Glyndebourne Festival and the Bavarian State Opera.
Gramophone Magazine, December 2013
For anyone who grew up , as I did, with the raw energy of Kondrashin on Melodiya in 1965, the sheer refinement and shapeliness of Ashkenazy's recording may take some getting used to. In this case, however, the gains easily outweigh any losses - the music simply feels more musical this way.
American Record Guide, January/February 2014
The soloist here is Shenyang, a young Chinese bass-baritone with an excellent grasp on the part and a more "international" sound than Vitaly Gromadsky, Kondrashin's bass. Kondrashin's chorus is more traditionally Russian, too. This Ashkenazy recording acquits itself well and has the advantage of modern sonics. In the end, while I'd like to hear the Schwarz recording Mr Hansen recommended, I'm quite happy with this sumptuous, polished, and expressive performance. The singers in the Finnish Suite do quite well - the soprano especially has a lighter voice that suits the folk-classical hybrid perfectly. Notes are in English and Finnish; the Razin text is in transliterated Russian and English, the songs in Finnish and English.
Recording information: Helsinki Music Centre (03/22/2013-03/23/2013).
ReviewsThere are currently no reviews, be the first one!
Also Purchased
Knudage Riisager (1897-1974): Violin Works / Johannes Soe Hansen, violin; Anne Soe Iwan, violin; Christina Bjorkoe, piano
Enescu: Piano Trio; Piano Quintet; Aria and Scherzino / Remus Azoitei, violin
Prokofiev: Complete Works for Violin: Concertos, Sonatas / James Ehnes, violin; Andrew Armstrong, piano. BBC SO, Noseda
Shostakovich: Symphonies Nos. 1 & 6 / Andrey Boreyko
Fauré: Theme et variations; Valses caprices; Nocturnes; Ballade / Angela Hewitt, piano
Medtner: Violin Sonatas Nos. 1 & 3 / Chloe Hanslip, violin; Igor Tchetuev, piano
George Enescu: Complete Violin Sonatas, Vol. 1 / Axel Strauss, violin; Ilya Poletaev, piano
The Unknown Sibelius: Rarities and First Recordings / Anne Sofie von Otter & Monica Groop, mz; Jorma Hynninen, baritone
Jennifer Higdon: Sky Quartet; Amazing Grace; Sonata for Viola and Piano; Dark Wood; String Trio / Serafin Quartet
Works DetailsShostakovich, Dmitri : The Execution of Stepan Razin, cantata, for bass, chorus & orchestra, Op. 119
- Performer: Shenyang (Bass Baritone)
- Conductor: Vladimir Ashkenazy
- Ensemble: State Choir Latvija
- Notes: Helsinki Music Centre (03/22/2013-03/23/2013)
- Running Time: 25 min. 43 sec.
- Period Time: Modern
- Form: Cantata/Oratorio
- Written: 1964
Shostakovich, Dmitri : Zoya (Who Is She?), suite from the film score, Op. 64a (assembled by Atovmyan)
- Conductor: Vladimir Ashkenazy
- Notes: Helsinki Music Centre (03/22/2013-03/23/2013)
- Running Time: 28 min. 14 sec.
- Period Time: Modern
Shostakovich, Dmitri : Suite on Finnish Themes, for soprano, tenor & chamber ensemble
- Performers: Tuomas Katajala (Tenor); Mari Palo (Soprano)
- Conductor: Vladimir Ashkenazy
- Notes: Helsinki Music Centre (03/22/2013-03/23/2013)
- Running Time: 9 min. 51 sec.
- Period Time: Modern
- Written: 1939


text:
LA QUINTA, Calif. -- Mike Weir went with caution. Jay Haas
went for the green.
Weir opted to lay up on the final hole and turned that strategy
into his third consecutive birdie as he came from behind to win the
Bob Hope Classic on Sunday.
Haas hit his approach shot into the water in front of the green
and took a bogey that left him two shots back in second place.
Weir, winning his fourth tour title, closed with a 5-under-par
67 and was 30-under 330 for the five-day tournament. Haas had a 69
in the final round, most of which was played in gusting winds.
Weir insisted both he and Haas made the right decisions on the
18th fairway.
''My only option, really, was to lay up. If I hit 10 balls from
there, I might be able to get one on the green,'' he said. ''But I
felt I could lay it up to 80 or 90 yards, my wedge shot is right
into the wind, and I had the bank I could play into.''
He hit his wedge within 8 feet, and, needing two putts for the
win, made the birdie on the 543-yard par-5.
''That was a no-decision for Jay there, too. It's a definite go
from where he was. I would have done the same thing,'' Weir said.
Haas hit a good drive on No. 18, maybe too good, he said.
''I almost got too close,'' he said after his tee shot left him
195 yards to the green. ''I'd almost rather go in there with a
5-wood or something where I could stick it up in the air. I was
between a 4- and 5-iron, and I took the 4. I just mis-hit it a
little bit. I was a little surprised it didn't carry.''
Haas, who won the Hope in 1988 and led until late in the final
round last year before fading, added, ''I'll look back, I guess, on
the redeye tonight and think about what could have been.''
He wasn't the only player who ran into late trouble.
Tim Herron, four shots ahead of Weir and Haas heading into the
final round, struggled to a 75 that included a quadruple bogey on
No. 16.
He finished tied for third at 25 under with Chris DiMarco, who
shot 70.
The win by Weir, a native of Sarnia, Ontario, marks the sixth
straight tour event won by a foreigner, dating to the final two
tournaments of last year.
PGA officials believe foreign players have never won six tour
tournaments in a row, and the last time foreigners took the first
four events of the year was in 1927 when Tommy Armour and Bobby
Cruickshank of Scotland each won twice to begin the season.
Weir, who trailed Haas by three shots at the turn, caught him by
making a short birdie putt on No. 17 to go 29 under while Haas took
a par on the hole.
Playing conditions were ideal and scores very low for the first
four days of the 90-hole tournament, but swirling winds made club
selection difficult and made for higher scores on the final day.
David Gossett matched par to finish fifth at 24 under, and
defending champion Phil Mickelson, who came on strong after an
opening 70, had a 67 to finish in a tie with Pat Perez for sixth at
23 under. Perez shot 71.
Herron's troubles on the 364-yard, par-4 16th ran the gamut of
hazards -- sand, rocks and water -- as he took eight shots.
He hit his tee shot into a bunker, wedged his next shot off the
fairway and under a large rock, took a penalty, then hit over the
green and into the water. After another penalty, he pitched within
15 feet of the hole, but his putt from there curled just over the
rim of the cup, and he finally putted out.
''In hindsight, I think I could have beat 8,'' Herron said, his
sense of humor intact.
Last year, Haas led the Hope at 26 under with eight holes to go,
but bogeyed No. 13 to start a slide that wound up in a 74 that
dropped him into a tie for 16th.
The 32-year-old Weir, a fulltime tour player since 1998, had an
off year in 2002, when he had no top 10 finishes and slipped to
78th on the money list with $843,891. A year earlier, he was 11th
with $2.78 million.
The winners of the year's first four tournaments have an
aggregate score of 100 under par. Ernie Els was 31 under at the
Mercedes and 16 under at the Sony Open, and Vijay Singh was 23
under at Phoenix. ... Singh (Fiji) won the Tour Championship and
Luke Donald (England) the Southern Farm Bureau Classic to close out
last season and begin the streak of six straight wins by
foreigners, including the two this year by Els (South Africa) and
another by Singh.


text:
Quotes & Info
|VRTX > SEC Filings for VRTX > Form 10-Q on 3-Nov-2011
|All Recent SEC Filings
Quarterly Report
We are in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. In May 2011, we began marketing INCIVEK™ (telaprevir) in the United States for the treatment of patients with genotype 1 chronic hepatitis C virus, or HCV, infection. In October 2011, we submitted a New Drug Application, or NDA, in the United States and a marketing authorization application, or MAA, in the European Union for KALYDECO™ (ivacaftor/VX-770), the lead drug candidate in our cystic fibrosis, or CF, program.
In the third quarter of 2011, we generated earnings as a cashflow positive company, with net income attributable to us of $221.1 million and an increase in our cash, cash equivalents and marketable securities of $65.2 million. We recognized net revenues on sales of INCIVEK of $419.6 million in the third quarter of 2011, which was an increase of $345.1 million as compared to the second quarter of 2011. Our operating expenses also have been increasing on a quarterly basis because expenses related to our commercial organization and sales of INCIVEK have increased substantially. In order to maintain profitability and continue our investment in research and development activities, we will need to sustain or increase our product revenues in future quarters.
In September 2011, our collaborator, Janssen Pharmaceutica, N.V., or Janssen, obtained marketing approval for telaprevir from the European Commission. Janssen is marketing telaprevir under the brand name INCIVO™. We anticipate that royalties payable by Janssen to us on net sales of INCIVO will provide a secondary source of revenues beginning in the fourth quarter of 2011. In addition, we expect to begin receiving revenues from KALYDECO, if approved, in 2012.
We have ongoing Phase 2 clinical programs involving drug candidates intended for the treatment of HCV infection, CF, rheumatoid arthritis, or RA, and epilepsy, and have an ongoing Phase 1 clinical development program for VX-787, which is our first drug candidate intended for the treatment of influenza. We believe that our longer-term success will depend on our ability to continue to generate and develop innovative compounds for the treatment of serious diseases. As a result, we expect to continue investing in research programs directed toward the identification of new drug candidates and to develop and commercialize selected drug candidates that emerge from those programs, alone or with third-party collaborators.
Drug Development and Commercialization
Discovery and development of a new pharmaceutical product is a difficult and lengthy process that requires significant financial resources along with extensive technical and regulatory expertise and can take 10 to 15 years or more. Potential drug candidates are subjected to rigorous evaluation, driven in part by stringent regulatory considerations, designed to generate information concerning efficacy, side-effects, proper dosage levels and a variety of other physical and chemical characteristics that are important in determining whether a drug candidate should be approved for marketing as a pharmaceutical product. Most chemical compounds that are investigated as potential drug candidates never progress into formal development, and most drug candidates that do advance into formal development never receive marketing approval. Because our investments in drug candidates are subject to considerable risks, we closely monitor the results of our discovery research, clinical trials and nonclinical studies, and frequently evaluate our drug development programs in light of new data and scientific, business and commercial insights, with the objective of balancing risk and potential. This process can result in relatively abrupt changes in focus and priority as new information becomes available and we gain additional understanding of our ongoing programs and potential new programs.
If we believe the data from a completed registration program support approval of a drug candidate, we would submit an NDA to the United States Food and Drug Administration, or FDA,
requesting approval to market the drug candidate in the United States. We or our collaborators also may seek analogous approvals from comparable regulatory authorities in foreign jurisdictions, such as an MAA in the European Union. To obtain approval, we must, among other things, demonstrate with evidence gathered in nonclinical studies and well-controlled clinical trials that the drug candidate is safe and effective for the disease it is intended to treat and that the manufacturing facilities, processes and controls for the manufacture of the drug candidate are adequate. The FDA and foreign regulatory authorities have substantial discretion in deciding whether or not a drug candidate should be granted approval based on the benefits and risks of the drug candidate in the treatment of a particular disease, and could delay, limit or deny regulatory approval. If regulatory delays are significant or regulatory approval is limited or denied altogether, our financial results and the commercial prospects for the drug candidate involved will be harmed.
We believe that by focusing on serious diseases and innovative drugs that have the potential to provide significant advantages over existing therapies, we can increase the likelihood that our drug candidates, if approved, will be commercially successful. Our marketing efforts for INCIVEK in the United States have focused on establishing effective marketing, distribution and pricing strategies; infrastructure to support commercial sales; appropriate and sustained levels of INCIVEK inventory; company-wide processes and systems to support compliance with applicable laws and regulations and post-marketing safety evaluations; and an effective sales force and managed markets organization to promote INCIVEK to healthcare providers and payors. We plan to continue to focus on our marketing efforts for INCIVEK and are in the process of negotiating with various government agencies and managed market organizations in an effort to expand the availability and extent of reimbursement from these third-party payors.
We believe that initial sales of INCIVEK have confirmed its commercially competitive profile, and to date a significant group of patients with genotype 1 HCV infection have sought treatment with an INCIVEK-based treatment regimen. We and Janssen are competing with Merck & Co., Inc.'s Victrelis™ (boceprevir), another HCV protease inhibitor that was approved for sale in the United States and Europe in 2011. KALYDECO (VX-770), if approved, would be the first drug to treat the underlying cause of CF in any patient population. However, it is difficult to predict future revenues that will be generated by telaprevir or by KALYDECO (VX-770), if it receives regulatory approvals, and we may need to adjust our business plan if demand declines or if our product revenues decrease based on competition from current or future therapies. Drugs that obtain market acceptance may later be rendered obsolete or noncompetitive by the introduction of additional therapies, expiration of intellectual property protections or introduction of generic competition. Medivir AB, in collaboration with Janssen, is currently evaluating an HCV protease inhibitor in Phase 3 clinical trials in combination with pegylated-interferon, or peg-IFN, and ribavirin, or RBV. In earlier-stage clinical trials, we are evaluating combinations involving VX-222, including all-oral combinations, and numerous competitors are evaluating protease inhibitors, HCV polymerase inhibitors and HCV NS5A inhibitors, including such competitors' all-oral combinations. We believe that these earlier-stage drug candidates, if approved, will not be available until several years from now. Approved drugs continue to be subject to, among other things, numerous regulatory risks, post-approval safety monitoring and risks related to supply chain disruptions.
We require a supply of INCIVEK for sale in North America and will require a supply of KALYDECO (VX-770) for sale worldwide if we are successful in obtaining marketing approval for KALYDECO (VX-770). We rely on an international network of third parties to manufacture and distribute our drug candidates for clinical trials, and we expect that we will continue to rely on third parties for the foreseeable future to meet our commercial supply needs for INCIVEK and any of our drug candidates that are approved for sale. Third-party contract manufacturers, including some in China, supply us with raw materials, and contract manufacturers in the European Union and the United States convert these raw materials into drug substance and convert the drug substance into final
dosage form. Establishing and managing this global supply chain requires a significant financial commitment and the creation and maintenance of numerous third-party relationships. Although we attempt to effectively manage the business relationships with companies in our supply chain, we do not have complete control over their activities. Also, because of the significant lead times required to manufacture our commercial supply of INCIVEK, we may have less flexibility to adjust our supply in response to increased demand than if we had shorter lead times.
We had not marketed pharmaceutical products before we obtained approval for INCIVEK, and prior to 2010 we had a relatively small commercial organization. As a result, in the past many of the regulations related to the marketing of pharmaceutical products had limited applicability to our business. As we expanded our commercial organization, we focused on implementing a comprehensive compliance program to actively identify, prevent and mitigate risk through the implementation of compliance policies and systems and the promotion of a culture of compliance. Among other laws, regulations and standards, we are subject to various federal and state laws pertaining to healthcare fraud and abuse, including anti-kickback and false claims statutes. Anti-kickback laws make it illegal for a prescription drug manufacturer to solicit, offer, receive or pay any remuneration in exchange for, or to induce, the referral of business, including the purchase or prescription of a particular drug. False claims laws prohibit anyone from presenting for payment to third-party payors, including Medicare and Medicaid, claims for reimbursed drugs or services that are false or fraudulent, claims for items or services not provided as claimed or claims for medically unnecessary items or services. We expect to continue to devote substantial resources to maintain, administer and expand these compliance programs.
Recent Developments
ş •
ş In August 2011, we obtained approval to market INCIVEK in Canada for patients who have genotype 1 chronic HCV.
ş •
ş In September 2011, Janssen obtained approval from the European Commission to market INCIVO in the European Union. Janssen currently is marketing INCIVO in the United Kingdom, Germany, France and Sweden.
ş •
ş In September 2011, Mitsubishi Tanabe obtained approval to market telaprevir in Japan, which it plans to market under the brand name TELAVIC™.
ş •
ş We have ongoing Phase 3b clinical trials to support potential supplemental applications for INCIVEK, including a clinical trial evaluating a twice-daily dosing regimen of INCIVEK and a clinical trial evaluating shorter treatment durations for patients with genotype 1 chronic HCV with a specific genetic variation near the IL28B gene referred to as the "CC" variation. We also plan to initiate a Phase 3b clinical trial of INCIVEK in patients co-infected with HCV and HIV, as well as a Phase 2b clinical trial of INCIVEK in patients with recurrent HCV following a liver transplant.
ş •
ş We have completed enrollment in two, all-oral three-drug treatment arms of an ongoing Phase 2 clinical trial evaluating our HCV polymerase inhibitor VX-222 in combination with INCIVEK and RBV.
ş •
ş In October 2011, we submitted our NDA in the United States and our MAA in the European Union for KALYDECO (VX-770). KALYDECO (VX-770) has been evaluated in patients with CF 6 years of age and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator, or CFTR, gene. We requested Priority Review of
the NDA from the FDA in the United States and have received agreement from the European Medicines Agency for accelerated assessment of KALYDECO (VX-770) in the European Union.
ş •
ş In October 2011, we initiated the second part of a Phase 2 clinical trial evaluating combination regimens of KALYDECO (VX-770) and VX-809, a corrector compound, in patients with the F508del mutation in the CFTR gene. In 2012, we plan to conduct a Phase 2 clinical trial of VX-661, another CFTR corrector compound.
ş •
ş In 2012, we plan to initiate a Phase 2 clinical trial of KALYDECO (VX-770) dosed as a monotherapy in patients ages 2 through 5 years who have at least one copy of the G551D mutation in the CFTR gene, as well as additional clinical trials designed to evaluate KALYDECO (VX-770) dosed as a monotherapy in patients with certain gating mutations in the CFTR gene other than the G551D mutation.
ş •
ş In September 2011, we announced data from our Phase 2a clinical trial that evaluated VX-509 in patients with RA over a twelve-week period. Based on the safety and efficacy data from this clinical trial, we plan to evaluate VX-509 as part of a six-month Phase 2b clinical trial in patients with RA. In this Phase 2b clinical trial, we expect to evaluate once-daily and twice-daily doses of VX-509 in combination with methotrexate, a commonly prescribed disease-modifying antirheumatic drug that is frequently used in combination with other RA drugs.
ş •
ş In the third quarter of 2011, we incurred an intangible asset impairment charge related to VX-759, the back-up HCV polymerase inhibitor to VX-222. Please refer to Note L, "Acquisition of ViroChem Pharma Inc.," in the accompanying notes to the condensed consolidated financial statements for further information.
Critical Accounting Policies and Estimates
Our discussion and analysis of our financial condition and results of operations is based upon our condensed consolidated financial statements prepared in accordance with generally accepted accounting principles in the United States. The preparation of these financial statements requires us to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reported periods. These items are monitored and analyzed by management for changes in facts and circumstances, and material changes in these estimates could occur in the future. Changes in estimates are reflected in reported results for the period in which the change occurs. We base our estimates on historical experience and various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ from our estimates if past experience or other assumptions do not turn out to be substantially accurate. During the nine months ended September 30, 2011, there were no material changes to our critical accounting policies as reported in our Annual Report on Form 10-K for the year ended December 31, 2010, as updated by our Quarterly Report on Form 10-Q for the quarter ended June 30, 2011.
Results of Operations-Three and Nine Months Ended September 30, 2011 Compared with Three and Nine Months Ended September 30, 2010
Three Months Increase/ Increase/ Nine Months Increase/ Increase/ Ended September 30, (Decrease) (Decrease) Ended September 30, (Decrease) (Decrease) 2011 2010 $ % 2011 2010 $ % (in thousands) (in thousands) Revenues $ 659,200 $ 23,795 $ 635,405 2,670 % $ 847,286 $ 77,846 $ 769,440 988 % Operating costs and expenses 443,493 223,383 220,110 99 % 957,368 607,289 350,079 58 % Gain (loss) on other items, net 5,403 (9,369 ) n/a n/a (18,973 ) (44,791 ) (25,818 ) (58 )% Net income (loss) attributable to Vertex $ 221,110 $ (208,957 ) n/a n/a $ (129,055 ) $ (574,234 ) $ (445,179 ) (78 )%
Net Income (Loss) Attributable to Vertex
In the third quarter of 2011, we had net income attributable to Vertex of $221.1 million. Our increased revenues were the result $419.6 million of INCIVEK net product revenues and $200.0 million in milestone revenues from Janssen recognized in the third quarter 2011, for which there were no comparable revenues in third quarter of 2010. Our increased revenues were partially offset by increased operating costs and expenses in the third quarter of 2011 as compared to the third quarter of 2010. A significant portion of the increase in operating costs and expenses was due to a $105.8 million impairment charge that we incurred in the third quarter of 2011 related to VX-759, a back-up HCV polymerase inhibitor that we determined was impaired based on, among other factors, the advancement of our lead HCV polymerase inhibitor VX-222. The remaining $114.3 million increase in operating costs and expenses in the third quarter of 2011 as compared to the third quarter of 2010 was principally attributable to a $61.8 million increase in sales, general and administrative expenses and a $35.3 million increase in costs of product revenues. Our operating costs and expenses in the third quarter of 2011 and 2010 included $29.4 million and $23.8 million, respectively, of stock-based compensation expense.
Our net loss attributable to Vertex in the nine months ended September 30, 2011 decreased as compared to our net loss attributable to Vertex in the nine months ended September 30, 2010, due to significant increases in our revenues, partially offset by significant increases in our operating costs and expenses. Our increased revenues were the result of INCIVEK net product revenues recognized in the second and third quarters of 2011 and $250.0 million in milestone revenues from Janssen recognized in 2011, for which there were no comparable revenues in the nine months ended September 30, 2010. The increased operating costs and expenses were primarily the result of the expansion of our commercial organization, costs related to INCIVEK sales and marketing in the United States and the impairment charge we recorded in the third quarter of 2011. Our operating costs and expenses in the nine months ended September 30, 2011 and 2010 included $89.2 million and $67.6 million, respectively, of stock-based compensation expense.
Net Income (Loss) Attributable to Vertex per Share
Our net income (loss) attributable to Vertex for the third quarter of 2011 was $1.02 per diluted share as compared to ($1.04) per diluted share for the third quarter of 2010. Our net income (loss) attributable to Vertex for the nine months ended September 30, 2011 was ($0.63) per diluted share as compared to ($2.87) per diluted share for the nine months ended September 30, 2010.
Revenues Three Months Increase/ Increase/ Nine Months Increase/ Increase/ Ended September 30, (Decrease) (Decrease) Ended September 30, (Decrease) (Decrease) 2011 2010 $ % 2011 2010 $ % (in thousands) (in thousands) Product revenues, net $ 419,595 $ - $ 419,595 n/a $ 494,130 $ - $ 494,130 n/a Royalty revenues 8,539 8,173 366 4 % 24,610 21,842 2,768 13 % Collaborative revenues 231,066 15,622 215,444 1,379 % 328,546 56,004 272,542 487 % Total revenues $ 659,200 $ 23,795 $ 635,405 2,670 % $ 847,286 $ 77,846 $ 769,440 988 %
We began recognizing net product revenues on sales of INCIVEK in the United States in the second quarter of 2011. Our net product revenues in the third quarter of 2011 increased significantly as compared to the second quarter of 2011 as a result of month-over-month increases in net product revenues, and as a result of recognizing net product revenues for a full fiscal quarter in the third quarter of 2011 as compared to only the final five weeks of the second quarter of 2011.
In late September 2011, Janssen obtained approval from the European Commission and began marketing INCIVO in certain European countries. We expect that our royalty revenues related to INCIVO will increase significantly over the next several fiscal quarters as Janssen launches INCIVO in its territories. We also earned royalty revenues from Janssen on sales of INCIVO pursuant to an early access program that was authorized by the French government. In the three and nine months ended September 30, 2011, our royalty revenues reflect $1.3 million and $3.8 million, respectively, of royalty revenues due to sales of INCIVO by Janssen.
Our remaining royalty revenues in the three and nine months ended September 30, 2011, and all of our royalty revenues in periods prior to the second quarter of 2011, relate to sales by GlaxoSmithKline plc of HIV protease inhibitors that were discovered and developed pursuant to our collaboration with GlaxoSmithKline. In 2008, we sold our right to receive future royalties from GlaxoSmithKline with respect to these HIV protease inhibitors, excluding the portion allocated to pay a subroyalty on these net sales to a third party, in return for a one-time cash payment. We deferred the recognition of revenues from this sale and are recognizing these deferred revenues over the term of our agreement with GlaxoSmithKline under the units-of-revenue method. We recognize additional royalty revenues equal to the amount of a third-party subroyalty and an offsetting royalty expense for the third-party subroyalty payment.
Our collaborative revenues have fluctuated significantly on a quarterly basis. This variability has been due to, among other things: the timing of recognition of up-front payments and significant milestone revenues, the variable level of net reimbursement we have received for the telaprevir development program from Janssen and revenues from services we provided to our telaprevir collaborators through our third-party manufacturing network. In the third quarter of 2011, we recognized the final milestone revenues we expect to recognize from our collaboration with Janssen, and we expect that in future periods our collaborative revenues from existing collaborations will represent a small percentage of our total revenues. The table presented below summarizes our collaborative revenues for the three and nine months ended September 30, 2011 and 2010:
Three Months Ended Nine Months Ended September 30, September 30, 2011 2010 2011 2010 (in thousands) Janssen $ 207,720 $ 4,566 $ 272,894 $ 22,912 Mitsubishi Tanabe 19,500 11,056 45,858 32,650 Cystic Fibrosis Therapeutics Incorporated 3,846 - 9,794 - Other - - - 442 Total collaborative revenues $ 231,066 $ 15,622 $ 328,546 $ 56,004
We recognized $200.0 million in milestone revenues under our collaboration agreement with Janssen in the third quarter of 2011 related to the approval and launch of INCIVO in the European Union, and $50.0 million in milestone revenues under this collaboration agreement in the first quarter of 2011 related to the acceptance of the filing of the MAA for INCIVO. The $50.0 million milestone payment received in the first quarter of 2011 was applied to the redemption of $50.0 million of our secured notes due 2012, or 2012 Notes, as required pursuant to the terms of the 2012 Notes. The $200.0 million in milestone payments we were entitled to receive from Janssen based on the achievement of milestones in the third quarter of 2011 were reflected as accounts receivable, net on our condensed consolidated balance sheet as of September 30, 2011. We applied the proceeds from $105.0 million of these milestone payments, which were received in October 2011, toward the redemption of the remaining $105.0 million of 2012 Notes, and the other $95.0 million of these accounts receivable were paid directly to the purchaser of the remaining portion of these milestone payments. We do not expect to earn any additional milestones pursuant to our collaboration with Janssen, and we expect our future revenues related to the Janssen collaboration will primarily be reflected as royalty revenues.
In each of the three and nine months ended September 30, 2011 and 2010, we recognized $9.6 million and $28.7 million of deferred revenues from Mitsubishi Tanabe Pharma Corporation related to a one-time payment of $105.0 million that we received in 2009. We expect to continue recognizing $9.6 million of deferred revenues each quarter from the one-time payment of $105.0 million through the first quarter of 2012. In the second quarter of 2011, we began recognizing collaborative revenues pursuant to the April 2011 amendment to our collaboration agreement with the Cystic Fibrosis Therapeutics Incorporated.
Operating Costs and Expenses Three Months Ended Increase/ Increase/ Nine Months Ended Increase/ Increase/ September 30, (Decrease) (Decrease) September 30, (Decrease) (Decrease) 2011 2010 $ % 2011 2010 $ % (in thousands) (in thousands) . . .


text:
Neutropenia Center - Springfield, MO
- WebMD Physician Directory of Springfield Hematologist Doctors
- Related Neutropenia Articles
- Springfield Emergency Contacts
- Nearby Springfield Hospitals
- Find a Local Pharmacy on RxList - Springfield
Springfield Hematologist Doctors for Neutropenia
Type of Physician: Hematologist
What is a Hematologist? A subspecialty certification by the Board of Internal Medicine or Pathology; Hematologists treat diseases of the blood, spleen, and lymph glands such as anemia, clotting disorders, sickle cell disease, hemophilia, leukemia, and lymphoma. They perform special types of transfusions and biopsy the bone marrow for analysis.
Specialty: Hematology
Common Name: Blood Doctor
Hematologist Doctors in Springfield * results
- 2
Kyle J. Noskoviak
Pathology Services Springfield
1000 E Primrose St Ste 550
Springfield, MO 65807
(417) 269-4647
- 12 years experience
- 3 office location(s)
Don't see your city? Use the WebMD Physician Directory to expand your search.
Neutropenia facts
- Neutropenia is a condition in which the number of neutrophils (a type of white blood cell) in the bloodstream is decreased, affecting the body's ability to fight off infections.
- Neutropenia is defined ...
Other Related Neutropenia Articles
Emergency Contact for Springfield
- In case of Emergency, call 911
Nearby Springfield Hospitals results
- 1Lakeland Rgnl Hsptl
440 S Market Ave
Springfield, Missouri 65806
(417) 865-558
- 2Cox Medical Center-North
1423 N Jefferson Ave
Springfield, Missouri 65802
(417) 269-300
- 3Mercy Hospital
1235 E Cherokee St
Springfield, Missouri 65804
(417) 820-200
- 4US Medical Center Fed Prisoners
1900 W Sunshine St
Springfield, Missouri 65807
(417) 862-704
- 5Ozarks Community Hospital
2828 N National Ave
Springfield, Missouri 65803
(417) 837-400
- 6Cox Walnut Lawn Hospital
1000 E Walnut Lawn St
Springfield, Missouri 65807
(417) 269-980
- 7Lester E Cox Medical Center So
3801 S National Ave
Springfield, Missouri 65807
(417) 269-600
- 8Mercy Hospital-Aurora
500 Porter Ave
Springfield, Missouri 65605
(417) 678-212
- 9Citizens Memorial Hospital Dist
1500 N Oakland Ave
Springfield, Missouri 65613
(417) 328-600
- 10Missouri Rehabilitation Center
600 N Main St
Springfield, Missouri 65712
(417) 466-371
* Provider Directory Terms of Use:
The WebMD 'Provider Directory' is provided by WebMD for use by the general public as a quick reference of information about Providers. The Provider Directory is not intended as a tool for verifying the credentials, qualifications, or abilities of any Provider contained therein. Inclusion in the Provider Directory does not imply recommendation or endorsement nor does omission in the Provider Directory imply WebMD disapproval.
You are prohibited from using, downloading, republishing, selling, duplicating, or "scraping" for commercial or any other purpose whatsoever, the Provider Directory or any of the data listings or other information contained therein, in whole or in part, in any medium whatsoever.
The Provider Directory is provided on an "AS-IS" basis. WebMD disclaims all warranties, either express or implied, including but not limited to the implied warranties of merchantability and fitness for particular purpose. Without limiting the foregoing, WebMD does not warrant or represent that the Provider Directory or any part thereof is accurate or complete. You assume full responsibility for the communications with any Provider you contact through the Provider Directory. WebMD shall in no event be liable to you or to anyone for any decision made or action taken by you in the reliance on information provided in the Provider Directory.
The use of WebMD Provider Directory by any entity or individual to verify the credentials of Providers is prohibited. The database of Provider information which drives WebMD Provider Directory does not contain sufficient information with which to verify Provider credentials under the standards of the Joint Commission on Accreditation of Healthcare Organizations (JCAHO), National Committee for Quality Assurance (NCQA) of the Utilization Review Accreditation Committee (URAC).
By using the WebMD Provider Directory, you agree to these Terms and Conditions.


text:
Housekeeping Comments on Comments
posted by July 17 at 12:16 PMon
Over the last couple of years we've had hundreds of thousands of comments on Slog, most of them pertinent, witty, and intelligent. From time to time we've removed commentsmostly spam, completely off-topic posts, and incidents of someone impersonating someone else. We don't remove comments based on their ideological or political point of view.
We've never had a written comments policy, but we're thinking about adding one to our blogs. We're working on a definition of what's acceptable and where to draw the line in terms of hate speech, threatening language, and ad hominem attacks. Our goal is to maintain an environment that's lively, positive, and orderly, but not oppressive. What do you think of this plan? What guidelines should we set for comments?


text:
Information Theory
A section of Entropy (ISSN 1099-4300).
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Applications of Information Theory in the Geosciences (Deadline: 31 July 2016)
- Radar and Information Theory (Deadline: 30 August 2016)
No topical collections currently open for submissions.
Papers Published
Last update: 16 May 2014
Entropy EISSN 1099-4300 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert


text:
Comments about 'Utah Utes football notebook: Prolific JC running back signs with Utes'
- Oldest first
- Newest first
- Most recommended
Check out his Youtube video! two steps faster than anyone on the field.
- 8:21 a.m. Dec. 17, 2010
- Like (3)
- Report abuse
Who's Shany?
- 8:23 a.m. Dec. 17, 2010
- Like (1)
- Report abuse
This could be bad timing for Utah to announce this recruit, maybe their offer to Langi to come in and start immediately wasn't sincere. This may cement Langi going to Provo.
- 9:00 a.m. Dec. 17, 2010
- Like
- Report abuse
Hope this doesn't hurt the U in the Harvey Langi sweepstakes. We will need both of these guys next year in the PAC-12.
- 9:01 a.m. Dec. 17, 2010
- Like
- Report abuse
Harvey will sign also.
Many great running teams feature 2 backs.
Let's consider his options - he's leaning towards staying in Utah right now.
So his options are
BCS league - Utah
non BCS - tds
Real atheletic teammates - Utah
Real studious teammates - tds
Coach who knows winning is #1 - Utah
Coach who think winning is #6 - tds
Team proven TWICE it can run the table - Utah
Team that has proven it will NEVER run table - tds
Team that will compete for NC's - Utah
Team that will compete for S.F. bowl - tds
Team that doesn't lose bowl games. Ever - Utah
Team that is 5-20(or close to) in bowl - tds
No "honor" code - utah
"honor" code - tds
11-2 team - utah
6-7 or 7-6 team - tds
6 players picked in last NFL draft - utah
1 player picked in last NFL draft - tds
What a tough decision!
- 9:29 a.m. Dec. 17, 2010
- Like (4)
- Report abuse
that's great to hear about Christopher giving back to the community. Thanks for including that in the article.
- 9:54 a.m. Dec. 17, 2010
- Like (1)
- Report abuse
UCLA is desperate for recruites.....might pull out all the stops for langi
- 10:08 a.m. Dec. 17, 2010
- Like
- Report abuse
Don't pencil in Langi yet. He has to jump into the next level and who knows if he can make it as a Freshman. He's a great high school football player in UTAH, but that doesn't account for a lot. He is a wait and see. Besides, the Utes might have someone we don't know about yet. No one heard of Eddie Wide and we all saw what he did. Besides, the path Langi apparently is starting to take off the field might effect him.
- 11:19 a.m. Dec. 17, 2010
- Like
- Report abuse
Laser.... good luck with that... a couple of recruiting services are reporting its down to Utah or USC. Some other reports say he leaning towards staying in state.... if you read into both of these story lines? I like the common denomonator.
- 11:27 a.m. Dec. 17, 2010
- Like (2)
- Report abuse
Utes athletes are also expected to be studious (and are performing well on that front). If not, that would be a negative. And Kyle expects "honorable" conduct from his team, also a positive.
I'm no BYU fan, and while many of your other points are valid, there's no need to be ridiculous.
- 11:29 a.m. Dec. 17, 2010
- Like (4)
- Report abuse
You had better hope Langi signs before he watches the Vegas Bowl.
- 11:38 a.m. Dec. 17, 2010
- Like (1)
- Report abuse
I tend to agree with your assesment of Langi. Infact, I wouldn't be suprised if he ends up play LB in college.
This JC kid just might be a huge pick up.
- 11:39 a.m. Dec. 17, 2010
- Like
- Report abuse
Haha we have Hague and you don't
- 12:01 p.m. Dec. 17, 2010
- Like
- Report abuse
Let's be realistic here. Harvey wants to go to a great football team with other athletic talent. End of story.
When he's thinking about Utah he sees other athletes on a great football team.
When he's thiking about tds he sees students who pretend to be athletes on a mediocre(see 6-6)team.
This discussion is about whether harvey will come to the U. School does not really play into the deciding factor. He wants to play with other athletes. That is the point I was making.
- 12:36 p.m. Dec. 17, 2010
- Like
- Report abuse
Keep posting ute fans, you've driven away more than one athlete to BYU because of your "hate" speech. Cougar fans everywhere thank you. By the way Langi will love playing on ESPN 8-9 times year. Plus chances are better to win another National Championship at a school that has already won one. Also a Doak Walker award, or heck maybe a Heisman. The tradition is incredibly rich in Provo.
- 1:59 p.m. Dec. 17, 2010
- Like (1)
- Report abuse
Tradition doesn't matter to kids today. What kid is going to care that BYU won a MNC almost 10 years before they were born. Notre Dame has more tradition and they still struggle. You can talk all you want about tradition, but in the last 10 years Utah is much more impressive.
- 2:38 p.m. Dec. 17, 2010
- Like (1)
- Report abuse
Do the youngsters care about top 25 end of season rankings? Maybe some grads of a fine research institution can help them figure that one out.
- 2:46 p.m. Dec. 17, 2010
- Like
- Report abuse
On youtube he looks extremely quick and very elusive in the open field. However it doesn't look like he breaks a lot of tackles, or get a lot of yards after contact. He looks like a good addition, but will definitely need more of a power back to complement him.
- 3:24 p.m. Dec. 17, 2010
- Like
- Report abuse
This is an excellent athlete to help in the Ute backfield. He has speed and will need to work on YAC. If we can get Langi, that would be a huge addition! I doubt we can get other power backs like Tra Carson or Adonis Amere-Moore out of Colorado. So far we have Lucky Radley who still has yet to get an opportunity to showcase his speed/talent. Add to that John White and Jarrell Oliver out of Texas. We may have some good talent in the backfield. One thing must be addressed? QB, Coach Whitt needs to give incoming freshman Derrick Brown and Griff Robles a chance. Need to try something if this team is to have success in the Pac-12. Go UTES!
- 4:00 p.m. Dec. 17, 2010
- Like (3)
- Report abuse
Looks like a good addition.
Get Langi too!
Reloading before the season even ends.
Bring on the PAC!
- 4:04 p.m. Dec. 17, 2010
- Like (2)
- Report abuse
DeseretNews.com encourages a civil dialogue among its readers. We welcome your thoughtful comments.
— About comments
- Former Cardinals exec sentenced to 4 years in...
- Tom Holmoe says BYU 'excited' that Big 12...
- Poll: Many Brazilians think Olympic Games...
- AP source: ACC, ESPN to launch ACC Network in...
- BYU and the Big 12: A timeline of events
- NCAA: No. 1 overall seed to choose tourney...
- IOC explores legal options on banning all...
- ACC, ESPN extend deal to 2036 that includes...
- Tom Holmoe says BYU 'excited' that Big... 125
- Brad Rock: What BYU needs to nail down... 105
- Nine Big 12 candidates: The pros and cons 68
- Morning links: National college... 68
- Report: Houston AD meets with Pac-12... 60
- Big 12 Media Days social roundup:... 49
- Finding a Power 5 home for all BYU... 49
- Report: Tom Holmoe tells Big 12 he's... 40


text:
November 2014, TruckingInfo.com - Test Drives
By Jim Park
Eaton's Procision dual-clutch medium-duty automated transmission
promises automatic-like driver feel with manual performance attributes.
Tags: Dual-Clutch, Eaton, Transmissions, Automated Manual Transmissions, Quick Spin
October 2014, TruckingInfo.com - Editorial
By Rolf Lockwood
Why bother adding the ability to shift a crash box to the training required by a newbie driver?
Tags: Automation, Transmissions, Automated Manual Transmissions
April 2014, TruckingInfo.com - Feature
By Tom Berg
The swing continues toward heavy automated products, but manuals still dominate. Light and medium trucks are almost all 'shiftless.'
Tags: Volvo, Cummins, Eaton, Mack, Transmissions, Allison Transmission, Daimler Trucks North America, Automated Manual Transmissions
We offer e-newsletters that deliver targeted news and information for the entire fleet industry.
The expert, Brian Fletcher from Eaton, will answer your questions
Gates Offers 6 Heavy-Duty Water Pumps
Reyco Granning DM400e is Lighter Than Predecessor
Baldwin Filters Offers Aftermarket Filter Designed for Kenworth Models
ARI Introduces Driver Scorecard for Simple Analysis


text:
Summerland Fruit Stands
• A WorldWeb.com Travel Guide to Fruit Stands in Summerland, BC, British Columbia.
Blossom Fruit Stand
This roadside fruit stand features freshly picked seasonal fruit and vegetables.
Granny's Fruit Stand
As the name suggests, this fruit stand purveys good old fashioned, quality produce.
The Market
More than a fruit stand. They sell their own fruit and produce, including peaches, plums, apricots, nectarines and apples grown on our orchard. From their greenhouse and garden they sell a variety of lettuce, tomatoes, cucumbers, peppers and more. What they don't grow, they get from local farmers.
Trout Creek Fruit Stand & Nursery
More than a fruit stand, Trout Creek also features a selection of greenery for the garden.


text:
DALLAS -- Houston coach Art Briles today interviewed with
Baylor about the school's coaching vacancy.
Briles, who has led the Cougars to four bowls in five seasons,
returned to Houston after meeting with Baylor athletic director Ian
McCaw in Dallas.
McCaw refused comment late today when reached via cell phone.
The Associated Press reports Briles has not been offered the
job, but Briles still appears to be a front-runner to replace Guy
Morriss was fired November 19th, after going 18-40 overall.
Baylor has had 12 straight losing seasons
Briles is 34-28 in five seasons at Houston.
The Cougars (8-4) have already accepted an invitation to play in
the Texas Bowl on December 28th in Houston against an undetermined
Big 12 opponent.
Briles Interviews With Baylor
DALLAS -- Houston coach Art Briles today interviewed with


text:
Jackson Park gets upgrade
Published: Friday, February 18, 2011 at 4:30 a.m.
Last Modified: Thursday, February 17, 2011 at 7:20 p.m.
A new retaining wall is being installed this week behind Field 3 at Jackson Park, just in time for the start of youth baseball.
Last month, the Henderson County Board of Commissioners directed the county engineer's office and Parks and Recreation Department to make the retaining wall the top priority among a series of maintenance improvements scheduled for the park aimed mostly at visitor safety.
Commissioners last year allocated $600,000 from the county's capital reserve fund to pay for the various projects, which also include repaving and reconfiguring the park's main roadway and parking lots.
Part of the urgency in the retaining-wall project expressed by commissioners at their January meeting was the upcoming baseball season, with practices now just two weeks away and the season officially set to get under way in late March. The deteriorating cinder block wall that had been in place behind the well-used field had become not only an eyesore but a safety concern for families watching the games, they said.
Allison Landscaping & Stone began demolishing that wall last weekend, said David Berry, the county's construction manager, who added that he expects the new wall to be completed by this weekend.
Reader comments posted to this article may be published in our print edition. All rights reserved. This copyrighted material may not be re-published without permission. Links are encouraged.


text:
Leeds United Message Board
The clearout starts Wednesday with Warnock meeting the players to state who he wants to stay, the one thing I will say is he knows exactly what we need Warnocks words . "What we've got to use at Leeds is the advantage of the crowd. We've got to get pace into the side, power in the side, and we've got to get energy.
"We've got to get the crowd up and at them, not the other way round. At the minute they try and get us going." PACE POWER AND ENERGY!!!Sort: Newest | Oldest | Most Replied Expand all replies
Warnock sums it up well; but only iterating what Leeds fans have been saying all season.
- 1 Reply to Andrew
Great 1st signing strong no nonsense defender player of the year at Bournemouth and Pompey, Warnock not hanging about so if Clayton goes he has stated he can get better for his wage offered. Looks like he is going for Top players and utilising the smaller squad offering reasonable wages and not having 25 players wasting money! In Warnock I trust. M.O.T
Sounds good Lotto but he missed out the vital element " PACE, POWER, ENERGY", and the MONEY to buy players with those attributes! Jason Pearce of Pompey centre back looks good and first in but at what cost. Pompey paid £500k for him last year! Warnock says he hopes to have three in the bag by the end of May before he goes on his jollies. He reckons that we need about eight in total. Word has it that Pompey, QPR and Derby could supply the remainder. Interesting times ahead folks.
- 1 Reply to Tom
and PASSION to wear the shirt of LEEDS UNITED. M.O.T
Despite the poor season im quite optomistic about next year Lotto. Just hope its not another false dawn and we are left frustrated again come the start of the season.
If Colin can get us a team that has all the above atributes then im sure we will do well. Just keep Diouf away from ER.
- 1 Reply to Jez
As with the status of the Levis v Bates court case, "judgement pending" is what Leeds fans will have to live with until the start of next season.
Warnock's 'clear-out' of players from the Leeds camp on Wednesday will provide some evidence of intention (like key players being retained) but not enough to make a judgement. New players being recruited will provide further evidence. However, it will not be until we see evidence of Warnock's new team performing that we can judge all the rhetoric.
We have had years of meaningless rhetoric from Bates. For sure, Warnock's rhetoric is believable but, as the saying goes, the proof of the pudding is in the eating. I sincerely hope that Warnock will not be tucking into humble pie, served in an executive box at ER, next year!


text:
Patriot men battle through the Mid-South Conference home stretch
With just a handful of games left in the regular season, every game means something to the St. Catharine College Patriots.
For the men, it means a shot at a Mid-South Conference title and the challenge of maintaining a Top 20 standing in the NAIA rankings.
On the womens' side, though they have struggled at times during the heart of the season, head coach Lena Bramblett is preparing her team to peak as they enter the final weeks of the season.
For the latest on the SCC mens' and womens' basketball teams, visit our Athletic website at www.goscpatriots.com.
Some additional text about the news release, perhaps some images or embedded files here.


text:
California Xtracts, Zingiber Cough, Alcohol Free Syrup, 4 fl oz (118 ml) (Discontinued Item)
You purchased this item onView this order
Loyalty Program
- You earn loyalty credit for every order you place at iHerb!
- Loyalty credit is equal to 10% of the value of your order, excluding shipping charges.
- Your loyalty credit will be applied towards your next order as soon as your current order has shipped.
- Your loyalty credits are valid for up to 60 days from the date of your last purchase.
Shipping Weight:?0.92 lbs (0.42 kg)
Shipping Weight
The Shipping Weight includes the product, protective packaging material and the actual shipping box. In addition, the Shipping Weight may be adjusted for the Dimensional Weight (e.g. length, width & height) of a package. It is important to note that certain types of products (e.g. glass containers, liquids, fragile, refrigerated or ice packed) will often require protective packaging material. As such, these products will reflect a higher Shipping Weight compared to the unprotected product.
- Product Code: CXT-00516
- UPC Code: 898220005161
- Package Quantity: 4 fl oz (118 ml)
- Dimensions: 1.9 x 1.9 x 4.5 in, 0.55 lbs (0.25 kg)
- May help support healthy upper respiratory function*
- A blend of supportive herbs
- Herbal Supplement
- Kosher Parve
Suggested Use
1/2 tsp as needed or as directed by your healthcare professional. Can be diluted in hot water.
Shake well before using
Other Ingredients
Vegetable glycerin, honey, deionized water
Do not take during pregnancy or while nursing.
Keep out of the reach of children.
|Supplement Facts
|Serving Size: 1/2 teaspoon
|Servings Per Container: 48
|Amount Per Serving
|Xtracts Blend
Organic Fresh and Dry Ginger Root, Fresh Osha Root, Wild Cherry Bark, Licorice Root
|750 mg^
|^Herb Weight Equivalence
Each serving is equivalent to 6.000 mg of fresh Ginger
* Daily Value Not Established


text:
SACRAMENTO, Calif. — For the second time in less than two years, California prison officials caught Charles Manson, mastermind of one of the most notorious killing sprees in U.S. history, with a cell phone behind bars.
Guards at Corcoran State Prison found the phone on Jan. 6, according to prison spokeswoman Terry Thornton. Manson was charged with violating prison rules, but not with a crime, because there is no law in California that prohibits inmates from possessing phones. Thornton declined to provide any details about where Manson got the phone, or who he called, saying the case is still under investigation.
Manson called people in California, New Jersey and Florida with an LG flip phone found under his prison bunk in March 2009, Thornton said.
Thirty days were added to his sentence for the first offense, officials said. Manson is technically eligible for parole but will almost certainly die in prison for ordering the ritualistic murders of actress Sharon Tate and six others in 1969.
I would Like To Why This Man Sits In Prison, He Should Of Been Executed, While Laying on a Table Strapped Down, While They Cut Him Heart Out and Feed It To His Sick Followers, Truthfully they should of all been executed for what they did. They Were & still Are a Bunch of Sicko , ignorant So Called People, And He Still Defies authority figures and still gets his hands on something the the cell phones. WHY IS HE STILL ALIVE???????????
I think he is calling SP To give her hints
Just kidding you tight @ss
Uh, he WAS sentenced to death and then California abolished the death penalty. This was back in the mid-70s.
But I bet Charles Manson knows when to use capital letters. YOU ARE MURDERING GRAMMAR LADY
Is he trying to call Sharon Tate?
Oh, that Chuck is always up to something.
Was Charles doing phone sex again ?
it shows you how difficult these cell phone contracts are to break! at least it is truly a "cell" phone.
He's an Acorn phone volounteer for Obama
Charles Manson never killed anyone and never told anyone to commit these crimes,
He is an innocent person in prison since over 40 years, and those of you making false accusations should be ashamed.
Who cares if he has a cell phone? There are worst things going on in prison. He is harmless. The people who killed Sharon Tate and others had a mind and they were evil. Charles (Tex) Watson stated in his book that he killed all of the victims. The others did assist. Patricia Krenwinkle is just as evil by chasing Abagail Folger across the lawn with her knife.
They set out to kill 7 people on those two nights in August 1969. I don't care how many drugs they did, it is no excuse. They were still evil and deserve to remain in prison without parole.


text:
Ohio Interfaith Power and Light (OhIPL) is the Ohio affiliate of the national Interfaith Power and Light network and a project of the Ohio Council of Churches.
Read more about our mission, here.
SAVE THE DATE! Earthkeeping Summit 2016! We are excited about this opportunity to gather together around the environmental issues of our time. Put Saturday, September 24th (at the 4-H Center at OSU) on your calendar and watch for details.
We reached our mid-year fundraising matching goal of $7500.00! Thank you for your continuing support of the mission of OhIPL! All donations are appreciated. We couldn't do our work without your support. If you would like to make a donation to the cause of bringing the moral voice to climate change and to help reduce our carbon footprint, CLICK HERE!


text:
In This Section
Journal Forum
A Meta-Analysis of High Resolution Audio Perceptual Evaluation - June 2016
2 comments
Synthetic Reverberator - January 1960
3 comments
Sound Board: High-Resolution Audio - October 2015
4 comments
AES E-Library
An 18-Bit Digital-to-Analog Converter for High-Performance Digital Audio Applications
Design and implementation details of a new 18-bit digital-to-analog converter are presented. The device is suitable for digital audio applications requiring an unusually large dynamic range, low wide-band noise, high speed, and low distortion. Key design considerations include careful management of thermal effects, a low-glitch switching architecture, and isolation of parasitic noise sources.
Click to purchase paper as a non-member or login as an AES member. If your company or school subscribes to the E-Library then switch to the institutional version. If you are not an AES member and would like to subscribe to the E-Library then Join the AES!
This paper costs $33 for non-members and is temporarily free for AES members.
Learn more about the AES E-Library
Start a discussion about this paper!


text:
REDWOOD CITY, CA—Institutional Property Advisors, a brokerage division of Marcus & Millichap, has arranged the sale of Township, a newly constructed 132-unit apartment complex in downtown Redwood City.
The $83 million sales price equates to approximately $628,800 per unit.
executive vice president investments Stanford Jones, vice president investments Philip Saglimbeni andvice president investments Salvatore Saglimbeni advised the seller, a joint venture between Sares Regis Group of Northern California and institutional investors advised by J.P. Morgan Asset Management.
"Apartment operations remain very healthy in Redwood City and throughout San Mateo County," said Jones. "Since reaching a cyclical peak in 2009, vacancy has declined at a healthy clip, decreasing 160 basis points. Redwood City currently demonstrates tremendous market fundamentals with approximately 9 % year-over-year market rent growth and an average occupancy of 96.1% reported as of the fourth quarter of 2013."
"Township is a luxury, pedestrian- and transit-oriented community located in the heart of Redwood City near numerous restaurants, cafes and extensive retail amenities," addedPhilip Saglimbeni. "The property represents the first new delivery of apartment product in over 12 years. The construction quality and attention to detail make this asset one of the premier rental communities on the mid-Peninsula."
The property is located at 333 Main St. in Redwood City, which is the geographical midpoint between San Francisco and San Jose. The community is situated within a quiet neighborhood one block from busy Veteran's Boulevard, four blocks from downtown and one-half mile from access to U.S. Route 101. The Redwood City Caltrain station is 0.70 miles from Township, providing residents with an attractive commuting option to major employment and entertainment centers in San Francisco, the Peninsula and the South Bay. The local employment base includes Oracle Corp., Electronic Arts, Shutterfly, Rocket Fuel, Stanford University, Facebook, Sony Computer Entertainment America LLC, Gilead Sciences and Life Technologies, and others.
Completed in early 2014, Township's four stories are accentuated with unique details, state-of-the-art amenities and views of the estuary to the east and Emerald Hills to the west. The community offers a diverse mix of well-designed and amenitized one-, two- and three-bedroom floor plans averaging 914 square feet. Residents enjoy a truly comprehensive amenity package, as the property provides a state-of-the-art fitness center with cardio-theater, heated whirlpool spa, a contemporary lounge with a fully equipped kitchen and a resident business center, as well as an outdoor kitchen barbecue and dining area and courtyard lounge area with TV and Zen fountain.
Apartment amenities include private patios and balconies in most homes, designer-selected cut-pile carpeting, stainless-steel Whirlpool appliances, solid-surface stone countertops, espresso flat-panel cabinetry with European hardware, in-home full-size washer and dryer, recessed lighting throughout, walk-in closets in many plans, oversized windows and extra-deep soaking tubs.


text:
Earl-Approved Dip!
Total Time
Prep 5 mins
Cook 0 mins
That's right, Earl the cat vouches for this. No, he hasn't tasted it, he just said, "Yeah, sure, go ahead and post it" when I ran it by him. Well, that's not entirely true, he actually just looked at me and nodded. Ok, he slept right through my question, big deal! Feta, sour cream, cumin, scallions...
Ingredients Nutrition
- 1 cup sour cream
- 1 plum tomato, diced
- 2 fresh serrano chilies, diced
- 1⁄4 cup scallion, chopped
- 1⁄2 cup feta cheese, crumbled
- 1 teaspoon cumin seed, toasted and crushed with mortar and pestle
- 1 pinch salt
- tortilla chips
- Combine all ingredients except tortilla chips and mix well. Chill until ready to serve.
Most Helpful
Totally Buster-Approved! He was CHOWING on this dip when I busted him! LOL, he just hunkered down & kept on going instead of scramming - tasted it & I know why - this is mighty toothsome! Served w/thin tortilla chips & partnered with a fresh salsa (which Buster didn't deign to touch). Will keep this recipe & make again (next time not sticking hot pepper finger in eye absentmindedly -;)). Thank you, Sandi, for this yummo recipe - from Buster & me
Oh, this was so delicious! I have to admit, I got a bit lazy and didn't grind the cumin after toasting it...it was still yummy. Also, I used jalapeno instead of serrano (I'm a kind of a wimp). Thanks for the recipe, Earl (I mean...Sandi!). P.S. Sandi, your intro cracked me up. :)


text:
We have a clear set of principles which will unlock the real potential of ONE Kingfisher. We are organising ourselves very differently in order to effect the necessary change, and we are getting on with this at real pace.
Share price at 17:13 BST London
+2.30p +0.69%
Véronique Laury interview
By putting the customer first, we will create a business that will better address their needs. We have the scale, the expertise and the passion, and by directing it with a unified focus we can truly make a difference.
Q1 trading update
Our Q1 results were announced on 24 May 2016.
Final results 2015/16
Our Final results were announced on 23 March 2016.
Q2 pre-close trading update
We announced our Second Quarter pre-close trading update on 23 July 2015
Preliminary results
Our Preliminary results were announced on 25 March 2014.
Our strategy
In January 2016 we provided the detail about our ONE Kingfisher transformation plan.


text:
My name is Adriana Aldrey-Ng, this is my personal website designed in collaboration with my team at OFF unit to showcase my skills and expertise in Graphic Design.
A Little Bit About Me…
I'm a graphic designer based in South Florida with 8+ years of experience.
As a freelancer I am more productive and more creative, since then I've been working on my own and enjoying it!
I have a particular love for branding and logo making… This is the kind of job that doesn't feel like a job at all and I can do this for the rest of my life with a smile on my face.
My Skills
Here is a breakdown of my skills in design and some random facts about quirky little me!
"Every artist was first an amateur." – Ralph Waldo Emerson
Work Experience
On my own schedule I work one-on-one with my clients and I can manage my time to give each project the focus it needs. It's the ideal environment for any creative job, distraction and stress free.
Lead Graphic Designer
As a member of the OFF unit graphic collective I am responsible for translating the creative ideas into designs. As a team we work with the client to find beautiful solutions to their branding needs. Day to day duties include design and production of icons, artwork, logos, and complete branding packages.
Graphic Designer
Semprenoi International Group Venezuela
Semprenoi is one of the top Advertising Agencies in Venezuela. During my time there I had the opportunity to work with the Art Directors to brainstorm and come up with ideas and concepts that reflect the strategy and message of the client's brand. As part of the design team I designed and produced media in a variety of styles for each client's needs. Additional tasks included design and production of copy layouts for publications such as magazines, newspapers, television, digital media and packaging.
Editorial Graphic Designer
At CIMA I started my professional career. During my tenure I took on many responsibilities including coordinating sales teams to meet with clients to discuss needs for their advertisements requirements. I also got to work closely with the creative and editorial team on designing and producing the layout, copy, proofing and preparing files for printing.


text:
-Fletcher Aldredge, publisher of the Vref Aircraft Value Reference, whose data shows larger declines in price for light jets in recent quarters than for any other market segment. Source: Architectural Digest
People » Quote/Unquote
December 1, 2008
October 1, 2008
-Steven Stolman, one of the new breed of hitchhikers who hop free rides on friends' private jets, explaining the "rules of the road" Source: The New York Times
August 1, 2008
-Sandals Resorts owner Gordon "Butch" Stewart, in his Center Stage interview.
February 1, 2008
XOJet CEO Paul Touw, commenting on air-taxi VLJ operations
December 1, 2007
-Pro golfer Douglas Tewell
October 1, 2007
-Texas billionaire Robert M. Bass, who is financing an effort to build the world's first supersonic business jet
August 1, 2007
-Shanghai-based journalist James Fallows, in The Atlantic
June 1, 2007
-Warren Buffett, in his typically folksy annual letter to stockholders of Berkshire Hathaway, which owns NetJets
April 1, 2007
-Canadian businessman Al Kroontje, on his first flight in his Sierra Stallion, a converted Citation 501SP with enhanced range and speed.
February 1, 2007
-60 Minutes producer John Hamlin, in The New York Times
"If you want to make one New Year's resolution that's actually doable, incredibly powerful, and sustainable for the entire year, make it your goal to take full responsibility for your health every single day no matter what life throws at you. "
-Dr. David Agus, in his book The End of Illness
Most Popular
June 26, 2016
July 3, 2016
July 20, 2016
July 10, 2016
July 18, 2016
July 20, 2016
July 1, 2016
July 5, 2016
July 5, 2016
February 1, 2012
January 12, 2012
December 1, 2011
May 30, 2013
December 5, 2012
November 26, 2012
April 30, 2012


text:
I did a test boot with just the CPU and power supply hooked up to the motherboard. I tried to short the 2 power pins on the motherboard, but that didn't work. However, when I shorted all of the pins, the fans spun up and I got a POST beep. I proceeded to put everything in the case and power it on. However, it doesn't power on when I press the power button on the case. I have the power cords from the case plugged in, as well as the reset and HDD LED cords. Any ideas on why it's not booting?
No fans ever spin up fully, however one of the case fans kind of jolts about 3/4 times that I press the power on button on the case.


text:
Video Industry News Video Company News Technology Industry News Technology Company News Novelty Industry News Novelty Company News Gay Industry News Gay Company News Legal Industry News All Company News
Released: Jun 01st, 2006
Running Time: 169
Director: Mark Anthony (I)
Company: MVP Entertainment
Distribution Companies: Evasive Angels
Cast: Tara Moore, Sophie Dee, Loni, Krystal Lynn, Heather (I), Wendy Wild, Kala, Charlotte Strokely, Monica (I), Erin Moore, Venus (I), Mysti May, Alikat, Brooklin Knight, Laveah, Hilary Scott, Stephie Wild, Samantha (I), Others
Critical Rating: AA 1/2
Genre: Gonzo
There's nothing new or particularly interesting about this collection of scenes. Whether poolside or in some seedy office, white girls suck off black guys without a lot of variation.
With such a big cast there's bound to be some interesting performances, and there are a few worth noting. Charlotte's milk white skin is a lovely contrast to her black stud?s. Venus and Sophie Dee also put on a great of show of enjoying their respective scenes. Loni's first time swallowing is absolutely adorable, though it's not enough to punch up this pedestrian effort.
Retailing: Stock only if interracial or b.j. vids do very well for you.


text:
WASHINGTON — Minutes before a midnight deadline, President Barack Obama signed into law a four-year extension of post-Sept. 11 powers to search records and conduct roving wiretaps in pursuit of terrorists.
"It's an important tool for us to continue dealing with an ongoing terrorist threat," Obama said Friday after a meeting with French President Nicolas Sarkozy.
With Obama in France, the White House said the president used an autopen machine that holds a pen and signs his actual signature. It is only used with proper authorization of the president.
Congress sent the bill to the president with only hours to go on Thursday before the provisions expired at midnight. Votes taken in rapid succession in the Senate and House came after lawmakers rejected attempts to temper the law enforcement powers to ensure that individual liberties are not abused.
The Senate voted 72-23 for the legislation to renew three terrorism-fighting authorities. The House passed the measure 250-153 on an evening vote.
A short-term expiration would not have interrupted ongoing operations but would have barred the government from seeking warrants for new investigations.
Congress bumped up against the deadline mainly because of the stubborn resistance from a single senator, Republican freshman Rand Paul of Kentucky, who saw the terrorist-hunting powers as an abuse of privacy rights. Paul held up the final vote for several days while he demanded a chance to change the bill to diminish the government's ability to monitor individual actions.
The measure would add four years to the legal life of roving wiretaps, authorized for a person rather than a communications line or device; court-ordered searches of business records; and surveillance of non-American "lone wolf" suspects without confirmed ties to terrorist groups.
The roving wiretaps and access to business records are small parts of the USA Patriot Act enacted after the Sept. 11, 2001, attacks. But unlike most of the act, which is permanent law, those provisions must be renewed periodically because of concerns that they could be used to violate privacy rights. The same applies to the "lone wolf" provision, which was part of a 2004 intelligence law.
Paul argued that in the rush to meet the terrorist threat in 2001 Congress enacted a Patriot Act that tramples on individual liberties. He had some backing from liberal Democrats and civil liberties groups who have long contended the law gives the government authority to spy on innocent citizens.
Sen. Dick Durbin, D-Ill., said he voted for the act in 2001 "while ground zero was still burning." But "I soon realized it gave too much power to government without enough judicial and congressional oversight."
Sen. Mark Udall, D-Colo., said the provision on collecting business records can expose law-abiding citizens to government scrutiny. "If we cannot limit investigations to terrorism or other nefarious activities, where do they end?" he asked.
"The Patriot Act has been used improperly again and again by law enforcement to invade Americans' privacy and violate their constitutional rights," said Laura W. Murphy, director of the ACLU Washington legislative office.
Still, coming just a month after intelligence and military forces tracked down and killed Osama bin Laden, there was little appetite for tampering with the terrorism-fighting tools. These tools, said Senate Republican leader Mitch McConnell of Kentucky, "have kept us safe for nearly a decade and Americans today should be relieved and reassured to know that these programs will continue."
Intelligence officials have denied improper use of surveillance tools, and this week both FBI Director Robert Mueller and Director of National Intelligence James Clapper sent letters to congressional leaders warning of serious national security consequences if the provisions were allowed to lapse.
- Warriors' Draymond Green settles assault case...
- Ex-KKK leader David Duke runs for Senate: 'My...
- AP source: Clinton's choice for VP to be...
- Hillary Clinton selects running mate for...
- Self-assured, Kaine brings a steady hand to...
- Trump takes time from victory lap to swat at...
- California governor denies parole for Manson...
- AP Poll: Support grows among Americans for...
- Sarah Silverman: Bernie-or-bust Dems... 49
- Is Bernie Sanders an atheist? 39
- After turmoil, Sanders, Michelle Obama,... 31
- Dems' division, emails roil party on... 28
- Clinton wins historic nomination,... 27
- Watch live at the Democratic National... 25
- In wake of email hack, Democratic chair... 23
- Trump taunts claims that Russia hacked... 20


text: This is my first try at posting a team on smogon and I am trying to be original with the team concept of a BP team with more than one recipient This is my take on a BP team but it has the advantage of not being so do or die as it has 4 recipients so if one gets KOed you can set up another and one of the recipients can baton pass what do you think of this team and do you think I should use espeon, vaploreon or umbreon? I need lots of help please Ninjask@leftovers Careful. Evs 252hp/ 256 split between the defences[/FONT] Batton pass Swords dance Substitute Protect/double team/silver wind Speed passer. I think protect is the best option but I am not sure. Careful if I use protect, adamant if silver wind, otherwise timid/jolly. Marowak@bone club Adamant. Evs 4HP/252attack/252 speed Bonemerang Rock slide Swords dance Double edge/focus punch/brick break Pass speed to this and there's not much that can stop it. I think Double edge is best maybe focus punch Gorebyss@leftovers/pinch berry Calm. Evs 252hp / 256 split between the defences Batton pass Iron defence Amnesia Rest/surf Almost the only thing that cans BP both defences reasonably well. If the opponent has a physical poke I will use Iron defence if special Amnesia then wishpass to it later Mecham@leftovers[/FONT] Jolly. Evs: 252attack/252speed/4hp Focus punch/brick break Ice punch Thunder punch Batton pass BP sweeper with psudo bolt/beam. Focus punch is what I'll probably use. Metagross@leftovers Adamant. Evs 200hp/200attack/110speed Meteor mash explosion Pursuit Earthquake Last ditch attempt because it can't BP. Espeon@leftovers Modest. 252sp.attack/256 split between the defences Batton pass Wish Psychic calm mind/substitute/yawn/protect Wish passer/sp.sweeper. Not sure about last move possibly protect? Or Vaploreon@leftovers Bold. Evs 200hp/310 split between the defences Batton pass Wish Rest/sleep talk/ substitute/roar/surf /acid amour Rest/sleep talk/ substitute/roar/surf/acid amour Wish passer/tank. Could make it a rest talker but it wouldn't do much else. roar and sub are good options to. Or Umbreon@ leftovers Calm/careful. Evs 252 HP/ 256 split between the defences Baton pass Mean look Moonlight/wish Toxic/protect/double team/snatch Wish passer/tank. Could pass snatch boosts has more defences than the other two If its crap please say so nicely.


text:
Determine the year-to-year percentage annual growth in total net sales.
Based only on your answers to question #1, do you think the company achieved its sales goal of +10% annual revenue growth in 2009? Determine the target revenue figure, and explain why you do or do not feel that the company hit its target.
Next, use Micro Chip's Consolidated Statement of Operations for the year ended September 25, 2008. (attached) and answer questions 1 and 2.
Use the Percentage Sales Method and a 25% increase in sales to forecast Micro Chip's Consolidated Statement of Operations for the period of September 26, 2008 through September 25, 2009. Assume a 15% tax rate and restructuring costs of 5% of the new sales figure.
Discuss your results from question number #1. What assumptions have you made? Do any of your assumptions seem unreasonable?
To receive full credit on this assignment, please show all work, including formulae and calculations used to arrive at the financial values. Students using Microsoft Excel must provide an adequate explanation of the methodology used to arrive at that answer.


text:
NYC Parks Events Calendar
Get up, get out, and do something! Just about any day of the year, you can find something fun, informative, and healthy to enjoy at an area park. Feel free to browse the listings below, or use the search tools to find an event that matches your interests and location.
Viewing 41–50 out of 17,264 events
from January 30, 2013 (x) to April 25, 2026
Saturday, June 27, 2015
Central Park Tour: Conservatory Garden
at Vanderbilt Gate (in Central Park), Manhattan
11:00 a.m.–12:15 p.m.
Take a tour with Conservatory Garden staff and learn about the history of the only formal garden in Central Park, including its restoration by Central Park Conservancy.
Category: Nature, History, Tours
Pop-Up Audubon: Incredible Invertebrates
at Vanderbilt Street Playground (in Prospect Park), Brooklyn
11:00 a.m.–4:00 p.m.
Join the Prospect Park Alliance to explore the freshwater ecosystems of Prospect Park.
Category: Birding, Education, Nature, Best for Kids
GreenThumb Workshop: Birdhouse Building
at Clayton Williams Memorial Garden, Manhattan
11:00 a.m.–12:30 p.m.
Learn how to build a beautiful home for our feathered friends.
Category: Arts & Crafts, Education, Nature, Best for Kids
Stories at the Statue of Hans Christian Andersen
at Hans Christian Andersen Statue (in Central Park), Manhattan
11:00 a.m.–12:00 p.m.
Elizabeth Shepherd will tell the story "The Glass Coffin," by the Brothers Grimm. Mark Horn will tell the Nepali story, "Princess of the Vermillion Path".
Category: Best for Kids
Dog Run Clean-Up at Little Bay Park
at Little Bay Park Dog Run (in Little Bay Park), Queens
11:00 a.m.–3:00 p.m.
Please join us for a clean-up and gravel redistribution. Gloves and tools will be provided.
Category: Volunteer
Family Fitness Festival
at Williamsbridge Oval Recreation Center (in Williamsbridge Oval), Bronx
11:00 a.m.–3:00 p.m.
Come learn about how to keep your family healthy and happy! We will have cooking demonstrations, fruit salads, Zumba, bootcamp demos, and activities for the children.
Category: Arts & Crafts, Festivals, Fitness, Best for Kids, Seniors
at Hunt's Point Recreation Center, Bronx
11:00 a.m.–3:00 p.m.
Join NYC Parks for this popular annual event. Summerfest includes water balloons, an obstacle course, face painting and much more!
Category: Arts & Crafts, Festivals, Fitness, Best for Kids, Sports
Summer Family Day
at Morris-Jumel Mansion (in Roger Morris Park), Manhattan
11:00 a.m.–4:00 p.m.
Spend a lovely summer's afternoon playing colonial games, making arts and crafts, and taking a guided tour of Morris-Jumel Mansion.
Category: Arts & Crafts, Education, History, Best for Kids, Tours
Free Yoga in the Park
at Socrates Sculpture Park, Queens
11:00 a.m.–12:00 p.m.
Yoga classes are free and designed for all experience levels. Participants should wear comfortable clothing and, for yoga, bring a mat or a towel. Kripalu Yoga is a system of Hatha…
Category: Fitness, Waterfront, Outdoor Fitness
Drawing Workshop: Chalk and Talk
at Conference House Park Visitor Center (in Conference House Park), Staten Island
11:00 a.m.–1:00 p.m.
Dunes, Drawing and Dendrology is a new summer program, a thematic series of nature walks, talks, and art workshops, designed to encompass the various natural elements of Conference…
Category: Arts & Crafts
Pages:< Prev 1 2 3 4 5 6 7 8… 1727Next >
Related Information
- Get information on upcoming events directly in your inbox by signing up for our Email Newsletters.
- Know about an event that's not on the calendar? Send us a tip!
- Planning an event and considering hosting it in a park? Make sure to read our Planning an Event page.


text:
Meet the Jet Linx Corporate Team
Denny Walker, Founder & Chairman
Jet Linx Management Company
| Denny Walker founded Jet Linx Aviation in 1999 as a local fractional jet company serving the Omaha community, providing its clients with a local solution to their private jet travel needs.
Before founding Jet Linx Denny co-founded CardMember Publishing Corporation in 1989, a consumer services direct marketing company. It was ranked as the "Fastest Growing Company in Omaha" by the Omaha Chamber of Commerce in 1994 and was also recognized as #2 on Inc. 500's America's Fastest Growing Private Companies. Denny and his co-founder took the company public as MemberWorks Corporation in 1996 (NASDAQ:MBRS). Earlier endeavors include founding Walker Enterprises and being employed by First Data Resources and the IBM Corporation.
Jamie Walker, President
Jet Linx Management Company and Jet Linx Aviation
|Before joining Jet Linx Aviation in 2002 to help develop the company on a national scale, Jamie started his career in New York City in sales and marketing. Jamie is responsible for the business development and strategic vision of Jet Linx, including the launch of its Jet Card, Aircraft Management, and Base Partner programs. Jamie works daily with Jet Linx team members and Base Partners to further develop and enhance the company's programs, sales and marketing, branding, culture and industry relationships. The combination of these daily efforts contributes to the continued success and growth of Jet Linx on a national scale. Jamie is involved in the Omaha community through the Knights of Aksarben and is a member of YPO.
Craig Christianson, CFO
|Craig joined Jet Linx with a wealth of accounting experience. A certified CPA, Craig most recently served as Director of Acquisitions & Integration and Controller for United States Infrastructure Corporation, where he helped grow revenue from $55 million in 2005 to $100 million in 2011, and worked to integrate financial information, processes and more during the company's multiple acquisitions. Craig is a graduate of the University of Nebraska-Lincoln.
Tom Fredrickson, Vice President of Human Resources
|Tom Fredrickson is a proven leader with a results-driven focus and has developed and implemented policies to service over 4,500 employees. Before joining Jet Linx, Tom had 18 years experience in human resources leadership, including holding senior human resources positions at Universal Lubricants, LLC, United States Infrastructure Corporation/Consolidated Utility Services and Roberts Dairy. Tom works with all Bases and departments at Jet Linx and leads the human resources team in shaping policies, as well as recruiting and retaining industry-best talent.
Jason Vanis, Vice President of Flight Operations
|Jason has been an actively involved in the aviation industry since 1998. While attending the University of Nebraska at Omaha, he started flight training and received his private pilot's license in 1994. After obtaining a Bachelor's degree from UNO, with an emphasis in Aviation Studies, Jason joined a Part 135 Charter operator in Colorado, in a Flight Operations & Customer Service role. Towards the end of 2002, he moved back to his home state of Nebraska and joined Jet Linx Aviation. Jason was responsible for the oversight of the Flight Operations Department, coordinating the scheduling of the aircraft, crew scheduling and, most importantly, first class customer service. At the beginning of 2008, Jason and two others launched Aviation Integration to provide efficiencies and training to the aviation industry.
Jason returned to Jet Linx in 2010 to manage the Scheduling and Dispatch team, as well as oversee the development of process and procedures throughout the organization. In November of 2012, Jason was named VP of Flight Operations to provide leadership to the Operations, Charter, Flight Coordination, Client Services and Maintenance departments.
Jason is a past recipient of the UNO Aviation Institute Distinguished Alumnus Award for his service to the Aviation Institute as an alumnus and for accomplishments in his career endeavors.
Jay Vidlak, Vice President of Base Development
|After graduating from the University of Nebraska at Omaha in 1998 with a Bachelor's degree in Aviation Studies, Jay began his professional career in aviation with Mayo Aviation in Denver, CO. He served as a charter coordinator/flight operations specialist and was promoted to Flight Operations Manager a few months later.
Jay remained with Mayo Aviation until 2002, when he returned to his home state of Nebraska to begin his career with Jet Linx. In 2007, Jay was promoted to Vice President of Flight Coordination, where he was responsible for overseeing the Flight Scheduling and Charter Sales Department, crew scheduling, and the continual growth and development of a nationwide charter and private jet card program.
In early 2012, Jay assumed the role of VP of New Base Development, focusing on the start-up phase of new Jet Linx bases around the country. He now serves as the Vice President of Base Development, working with Base Presidents and Partners to develop, enhance and further manage current Jet Linx locations around the country.
Ray Bennett, Vice President of Sales
|Ray Bennett has over 20 years of experience in the aircraft industry. He graduated from Nebraska Wesleyan University in 1991 with a degree in Business Administration. His extensive sales and industry experience began as the Regional Sales Manager for Allied Signal Aerospace CAS in 1991. Following six years with Allied Signal Aerospace, he moved on to Raytheon Travel Air in 1997. During his tenure as Regional Sales Director, Ray received numerous awards for his sales performance, including the Raytheon Blue Chip award for four consecutive years. Ray has also served as Sales Vice President for NetJets, Inc. as well as Flight Options, LLC. In both roles, he refined sales processes while exceeding targets. Before joining Jet Linx, Ray served as Sales Director for Beechcraft, earning numerous accolades for his sales performance.
Ray is an avid cyclist, and has devoted himself to riding for the Nebraska chapter of Team in Training, raising money for Leukemia & Lymphoma research. He is also a cooking enthusiast and the father of two children. Ray is a licensed pilot in both single and multiengine aircraft and a licensed commercial pilot.
Trey Sutter, Vice President of Business Development
|A graduate of Georgia Tech, Trey is an IFR-rated private pilot and longtime member of the aviation industry. He has over 15 years of experience in aviation sales, including over ten years as a vice president in fractional jet and jet card businesses. Trey's focus as Vice President of Business Development is adding Base locations and Base Partners to the Jet Linx family.
Trey and his wife, Dotty, live in Nashville.
In Our Office
Michael Kopp
Director of Operations
Shane Sydzyik
Director of Flight Standards
Tony Boatwright
Director of Maintenance
Bruce Tuttle
Director of Compliance
Kari Johnson
Director of Safety
Erin Donnelly
Director of Fleet Optimization & Operator Relations
Jordan Maddex
Director of Marketing & Strategic Partnerships
Jeremy Parks
Director of IT
Steven Bruce
Quality Manager
Ashley Hinderaker
Missy Kemp
Client Services & Training Manager
Meric Reese
Flight Coordination Manager
Jonathan Hunter
Fleet Optimization Manager
Nick Johnson
Fleet Optimization Manager
Josh Carstensen
Crew Coordination Manager
Dick Goeken
Parts Manager
Elizabeth Schneider
Executive Assistant & Project Coordinator